Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
AXSM
AXSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest AXSM ETF News Today | Earnings, Events & Price Alerts
AXSM News
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
5d ago
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
5d ago
Newsfilter
UBS Increases Target Price for AXSOME THERAPEUTICS INC to $251, Up from $248
Feb 24 2026
moomoo
Wall Street Analysts Adjust Ratings on Key Stocks
Feb 24 2026
Benzinga
Axsome Reports Q4 Revenue Exceeding Expectations
Feb 23 2026
stocktwits
Axsome Therapeutics Q4 2025 Earnings Call Highlights
Feb 23 2026
seekingalpha
Axsome (AXSM) Q4 2025 Earnings Call Transcript
Feb 23 2026
NASDAQ.COM
Axsome Therapeutics Q4 Earnings Exceed Expectations
Feb 23 2026
seekingalpha
Wall Street Focus This Week: Nvidia Earnings Report
Feb 22 2026
CNBC
Axsome Therapeutics: A Decade of Investment Potential
Feb 22 2026
Fool
Investment Potential of Axsome Therapeutics
Feb 22 2026
Yahoo Finance
Axsome Therapeutics to Announce Q4 Earnings on February 23
Feb 20 2026
seekingalpha
NMRA-511 Shows Promising Results in Alzheimer's Agitation
Feb 17 2026
Benzinga
Axsome Therapeutics Stock Analysis Ahead of Earnings
Feb 13 2026
Yahoo Finance
Axsome Therapeutics Stock Soars 75% Amid Strong Growth
Feb 05 2026
Fool
Analyzing Future Growth Potential of Axsome Therapeutics
Feb 03 2026
Fool
Show More News
